Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, Germany. | Cancer Immunol Immunother | 2023 | 37872395 | PubTator, text mining | PubMed |
| Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV± cancer. | Nat Commun | 2023 | 37865647 | PubTator, text mining | PubMed |
| Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets. | Commun Biol | 2023 | 37864059 | PubTator, text mining | PubMed |
Value of three-dimensional visualization of preoperative prostatic magnetic resonance imaging based on measurements of anatomical structures in predicting positive surgical margin after radical prostatectomy. | Front Endocrinol (Lausanne) | 2023 | 37859989 | PubTator, text mining | PubMed |
| A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. | J Exp Clin Cancer Res | 2023 | 37858248 | PubTator, text mining | PubMed |
| From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress. | Signal Transduct Target Ther | 2023 | 37857607 | PubTator, text mining | PubMed |
| Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. | Cancer Drug Resist | 2023 | 37842234 | PubTator, text mining | PubMed |
| Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. | Front Immunol | 2023 | 37841237 | PubTator, text mining | PubMed |
| A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot Study. | J Clin Med | 2023 | 37834841 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection. | PLoS Pathog | 2023 | 37812637 | PubTator, text mining | PubMed |
Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases. | Contrast Media Mol Imaging | 2023 | 37810486 | PubTator, text mining | PubMed |
| Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity. | Breast Cancer Res | 2023 | 37805590 | PubTator, text mining | PubMed |
| Exosome, the glass slipper for Cinderella of cancer-bladder cancer? | J Nanobiotechnology | 2023 | 37805491 | PubTator, text mining | PubMed |
| TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. | Cancer Cell | 2023 | 37802053 | PubTator, text mining | PubMed |
| Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma. | Ann Med | 2023 | 37795794 | PubTator, text mining | PubMed |
| Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE. | Nat Commun | 2023 | 37794035 | PubTator, text mining | PubMed |
| An unbiased proteomic analysis of PAD4 in human monocytes: novel substrates, binding partners and subcellular localizations. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37778379 | PubTator, text mining | PubMed |
| Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies. | Transl Oncol | 2023 | 37776617 | PubTator, text mining | PubMed |
| Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma. | Anticancer Res | 2023 | 37772585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=14